Liposome-encapsulated doxorubicin compared with conventional doxorubicin in a randomized multicenter trial as first-line therapy of metastatic breast carcinomaHARRIS, Lyndsay; BATIST, Gerald; BELT, Robert et al.Cancer. 2002, Vol 94, Num 1, pp 25-36, issn 0008-543XArticle

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidinesLENZ, Heinz-Josef; VAN CUTSEM, Eric; TSUCHIHASHI, Zenta et al.Journal of clinical oncology. 2006, Vol 24, Num 30, pp 4914-4921, issn 0732-183X, 8 p.Article

Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckHERBST, Roy S; ARQUETTE, Matthew; SHIN, Dong M et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5578-5587, issn 0732-183X, 10 p.Article

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckBONNER, James A; HARARI, Paul M; OVE, Roger et al.The New England journal of medicine. 2006, Vol 354, Num 6, pp 567-578, issn 0028-4793, 12 p.Article